HWM-94393-81147
3 vaccinations
5 coded responses
39 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 681 / NE
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-29
-
2021-01-30
Survey response — days 1–6 daily, dose 1MedDRA: Dysmenorrhoea — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal painFree text: Mild menstrual crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: Dysmenorrhoea — Feeling: Good · Fatigue or tiredness, Abdominal painFree text: Menstral-like crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
-
2021-02-02
Survey response — days 1–6 daily, dose 1MedDRA: Swelling of eyelid — Feeling: GoodFree text: Swollen bottom eyelidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-04
- 2021-02-11
-
2021-02-18
Dose 2 — Pfizer-BioNTech
- 2021-02-18
- 2021-02-19
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Muscle spasms — Feeling: Good · Fatigue or tirednessFree text: Menstrual-like crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-25
- 2021-03-04
- 2021-03-13
- 2021-03-18
- 2021-03-25
- 2021-04-03
- 2021-05-20
- 2021-08-19
-
2021-12-30
Dose 3 — Pfizer-BioNTech
- 2021-12-30
-
2021-12-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-01
-
2022-01-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-03
- 2022-01-04
- 2022-01-05
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-02-10
-
2022-03-31
Survey response — 3 months, dose 3MedDRA: Premature labour — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Preterm labor symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-04-04
- 2022-06-30
- 2022-12-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2021-12-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Mild menstrual cramps
Systemic reaction (other): Menstral-like cramps
Systemic reaction (other): Swollen bottom eyelid
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Menstrual-like cramps
Release 11 — 3 months, dose 3
Symptoms: Preterm labor symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Premature labour | · | · | ✓ |
| SRO | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Swelling of eyelid | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release